ストックスクリーナーアプリを入手
3.90
2.74%
-0.11
Bionexus Gene Lab Corp (BGLC) 最新ニュース
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - ulpravda.ru
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is trending among retail tradersCEO Change & Weekly Top Gainers Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - ulpravda.ru
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Nigeria
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
BioNexus Chemrex leadership resignations prompt governance review - The Globe and Mail
Bionexus Gene Lab CorpMatthew L. Barsing appointed as chairman of Chemrex boardSEC filing - marketscreener.com
BioNexus Gene Lab Corp Evaluates CDMO Expansion - TradingView — Track All Markets
Inflation Data: Is BioNexus Gene Lab Corp. stock attractive after correctionQuarterly Portfolio Review & Daily Growth Stock Tips - DonanımHaber
What margin trends mean for BioNexus Gene Lab Corp. stockPortfolio Value Summary & Real-Time Volume Spike Alerts - DonanımHaber
Will BioNexus Gene Lab Corp. stock gain from lower inflation2025 Trade Ideas & Expert Approved Trade Ideas - DonanımHaber
Is BioNexus Gene Lab Corp. stock attractive after correction2025 Key Highlights & Growth Focused Entry Reports - DonanımHaber
Can BioNexus Gene Lab Corp. stock maintain growth trajectory2025 Market WrapUp & Stepwise Trade Execution Plans - Улправда
Bionexus Gene Lab completes investment in Fidelion Diagnostics - MSN
Analysis Recap: How BioNexus Gene Lab Corp stock valuations compare to rivalsStop Loss & Target Return Focused Stock Picks - moha.gov.vn
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Nigeria
Is BioNexus Gene Lab Corp. stock safe for conservative investorsWeekly Profit Summary & Stepwise Trade Execution Plans - Newser
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
A Look at BioNexus Gene Lab Corp (BGLC) Shares in the Recent Past Indicates Growth - setenews.com
Blue Gold Sets $15 Million Gold Trading Facility - marketscreener.com
Bionexus Gene Lab completes strategic investment in Fidelion Diagnostics, secures 15% equity stake in global AI Oncologic platform - MarketScreener
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics - Investing.com
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics By Investing.com - Investing.com South Africa
BioNexus Gene Lab Corp. Completes Strategic Transaction with Fidelion Diagnostics, Securing Exclusive Rights for VitaGuard™ in Southeast Asia - Quiver Quantitative
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard - marketscreener.com
BioNexus Gene Lab (NASDAQ: BGLC) acquires 15% Fidelion stake, VitaGuard ASEAN rights - Stock Titan
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™ - The Manila Times
BioNexus Gene Lab secures $500 million equity purchase agreement By Investing.com - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility - Investing.com Nigeria
BioNexus Gene Lab stock falls after securing $500M equity facility By Investing.com - Investing.com South Africa
BioNexus Gene Lab Shares Jump After Securing $500 Million Equity Facility - MSN
Bionexus Gene Lab secures $500M equity facility from ARC Group - TipRanks
BioNexus Gene Lab (BGLC) Stock Analysis Report | Financials & Insights - Benzinga
BioNexus Gene Lab secures $500 million equity purchase agreement - Investing.com
Bionexus Gene Lab Corp enters $500 million equity purchase agreement - marketscreener.com
BioNexus Gene Lab stock climbs after securing $500 million equity facility - Investing.com UK
BioNexus Gene Lab stock climbs after securing $500 million equity facility By Investing.com - Investing.com India
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization - The Manila Times
BioNexus Gene Lab (Nasdaq: BGLC) lines up $500M ARC equity facility for MRD, CDMO push - Stock Titan
Bionexus Gene Lab, Fidelion Diagnostics execute license for VitaGuard platform - TipRanks
Bionexus Gene Lab Corp to pay $2 million license fee to Fidelion - marketscreener.com
6.08%
2.02%
大文字化:
|
ボリューム (24 時間):